InsidersTradesSigma
한화생명 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 한화생명 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Banks sector, 한화생명 has recorded 215 public disclosures. Market capitalisation: €3,328.7bn. The latest transaction was filed on 3 July 2026 (Other). Among the most active insiders: 김국진. All data is free.
215
Insider Decl.
0
Thresholds
€8,932
55 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,418 of 25,571 companies
68.6
score / 100
Value95
Quality42
FCF yld·
Earn yld23%
EV/EBITDA4.5x
ROE6.2%
Gross mgn·
Net mgn4.4%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations215 total
25 of 215 declarations
About 한화생명
Hanwha Life is a South Korean insurance company that offers various life insurance products and financial services. It is listed on the XKRX.